Benitec Biopharma Inc. (NASDAQ: BNTC) Stock Information | RedChip

Benitec Biopharma Inc. (NASDAQ: BNTC)


$10.7000
+0.3200 ( +2.20% ) 40.8K

Benitec Biopharma Inc is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference with gene therapy for providing sustained, long-lasting silencing of disease-causing genes from a single administration. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The company is developing product candidates in chronic and life-threatening human disease areas including Orphan disease: Oculopharyngeal Muscular Dystrophy (OPMD) and Infectious disease: Hepatitis B Virus (HBV). BB-301 is currently under development by the group; it is designed to slow, or halt, the disease progression.

Market Data


Open


$10.7000

Previous close


$10.3800

Volume


40.8K

Market cap


$246.56M

Day range


$10.3050 - $10.9250

52 week range


$2.6900 - $13.2900

SEC Filings


Form Type Description Pages Date
8-k 8K-related 14 Dec 10, 2024
8-k 8K-related 13 Dec 06, 2024
sc Insider transactions 1 Dec 06, 2024
4 Insider transactions 4 Dec 05, 2024
4 Insider transactions 4 Nov 21, 2024
sc Insider transactions 1 Nov 18, 2024
8-k 8K-related 15 Nov 14, 2024
schedule Other 1 Nov 14, 2024
defa14a Other 1 Nov 14, 2024
8-k 8K-related 13 Nov 14, 2024

Latest News


× Before browsing our site, please accept our cookies policy